Show simple item record

dc.contributor.authorThe IPPIC Collaborative Network
dc.date.accessioned2021-03-17T15:40:01Z
dc.date.available2021-03-17T15:40:01Z
dc.date.issued2020-12
dc.identifier.citationThe IPPIC Collaborative Network 2020 , ' Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia : An individual participant data meta-analysis ' , Health Technology Assessment , vol. 24 , no. 72 , pp. 1-290 . https://doi.org/10.3310/HTA24720en
dc.identifier.issn1366-5278
dc.identifier.otherPURE: 189072880
dc.identifier.otherPURE UUID: 5c7b5811-c3e6-4fb9-a37f-c46412cae7a2
dc.identifier.otherScopus: 85098676628
dc.identifier.otherPubMed: 33336645
dc.identifier.urihttps://hdl.handle.net/2164/16069
dc.descriptionFunding Information: Declared competing interests of authors: Gordon CS Smith has received research support from Roche Holding AG (Basel, Switzerland) (supply of equipment and reagents for biomarker studies of ≈£600,000 in value) and Sera Prognostics (Salt Lake City, UT, USA) (≈£100,000), and has been paid by Roche to attend an advisory board and to present at a meeting. He is a named inventor on a patent filed by Cambridge Enterprise (UK Patent Application Number 1808489.7, ‘Novel Biomarkers’) for the prediction of pre-eclampsia and fetal growth restriction. Ignacio Herraiz reports personal fees from Roche Diagnostics and Thermo Fisher Scientific (Waltham, MA, USA). John Kingdom reports personal fees from Roche Canada (Mississauga, ON, Canada). Lucy C Chappell is chairperson of the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) CET Committee (January 2019 to present). Asma Khalil is a member of the NIHR HTA Board (November 2018 to present). Jane E Norman is a member of the NIHR HTA MNCH Panel, and she reports grants from NIHR and Chief Scientist Office Scotland, as well as consultancy fees from and participation in data monitoring committees for Dilafor AB (Solna, Sweden) and GlaxoSmithKline (Brentford, UK). Kajantie Eero reports grants from the Academy of Finland, the Foundation for Paediatric Research, the Signe and Ane Gyllenberg Foundation (Helsinki, Finland), the Sigrid Jusélius Foundation (Helsinki, Finland), the Juho Vainio Foundation (Helsinki, Finland), the European Commission, the NORFACE DIAL Programme, the Novo Nordisk Foundation (Hellerup, Denmark), the Yrjö Jahnsson Foundation (Helsinki, Finland), Foundation for Cardiovascular Research (Zürich, Switzerland) and the Diabetes Research Foundation. Ben W Mol reports fellowship from the National Health and Medical Research Council (Canberra, ACT, Australia), personal fees from ObsEva (Plan-les-Ouates, Switzerland), personal fees and consultancy fees from Merck Sharp & Dohme (Kenilworth, NJ, USA), personal fees from Guerbet (Villepinte, France), travel funds from Guerbet and grants from Merck Sharp & Dohme. Richard D Riley reports personal fees from the British Medical Journal for statistical reviews, and from Roche and the universities of Leeds, Edinburgh and Exeter for training on individual participant data meta-analysis methods. Jacques Massé reports grants from National Health Research and Development Program, Health and Welfare Canada, during the conduct of the study. Paul T Seed is partly funded by King’s Health Partners Institute of Women and Children’s Health, Tommy’s (registered charity number 1060508) and ARC South London (NIHR). The views expressed are not necessarily those of KHP, Tommy’s, the NHS, the NIHR or the Department of Health. Funding Information: The research reported in this issue of the journal was funded by the HTA programme as project number 14/158/02. The contractual start date was in December 2015. The draft report began editorial review in March 2019 and was accepted for publication in March 2020. The authors have been wholly responsible for all data collection, analysis and interpretation, and for writing up their work. The HTA editors and publisher have tried to ensure the accuracy of the authors’ report and would like to thank the reviewers for their constructive comments on the draft document. However, they do not accept liability for damages or losses arising from material published in this report. Funding Information: This report presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed by authors in this publication are those of the authors and do not necessarily reflect those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care. If there are verbatim quotations included in this publication the views and opinions expressed by the interviewees are those of the interviewees and do not necessarily reflect those of the authors, those of the NHS, the NIHR, NETSCC, the HTA programme or the Department of Health and Social Care. Funding Information: Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 72. See the NIHR Journals Library website for further project information. Funding Information: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 72. See the NIHR Journals Library website for further project information. Publisher Copyright: © 2020, NIHR Journals Library. All rights reserved. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.en
dc.format.extent290
dc.language.isoeng
dc.relation.ispartofHealth Technology Assessmenten
dc.rightsPermission to reproduce material from a published report is covered by the creative commons licence http://creativecommons.org/licenses/by/4.0/en
dc.subjectR Medicine (General)en
dc.subjectHealth Policyen
dc.subject.lccR1en
dc.titleValidation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia : An individual participant data meta-analysisen
dc.typeJournal articleen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Women’s Health Researchen
dc.contributor.institutionUniversity of Aberdeen.Centre for Health Data Scienceen
dc.contributor.institutionUniversity of Aberdeen.Clinical Medicineen
dc.contributor.institutionUniversity of Aberdeen.Data Safe Havenen
dc.description.statusPeer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.3310/HTA24720
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85098676628&partnerID=8YFLogxKen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record